Benztropine Mesylate Tablet
Product Images NDC 11534-167

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Benztropine Mesylate (NDC 11534-167). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sunrise Pharmaceutical, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C1789516-figure-01 (C1789516 Figure 01)

FDA Label Image

C1789516-figure-02 (C1789516 Figure 02)

This text provides information about Benztropine Mesylate Tablets, USP with a strength of 0.5 mg in a package containing 100 tablets. It includes details on the usual adult dosage for parkinsonism and drug-induced extrapyramidal disorders. The brand is manufactured and distributed by Sunrise Pharmaceutical, Inc. located in Rahway, NJ. It also gives instructions on storing the medication and keeping it out of children's reach. The NDC number for identification is 11534-167-09.*

FDA Label Image

C1789516-figure-03 (C1789516 Figure 03)

This text provides information about a medication called Benztropine Mesylate. Each tablet contains 1mg of the active ingredient. The typical adult dosage for parkinsonism is 1 to 2 mg daily, while for drug-induced extrapyramidal disorders, it is 1 to 4 mg once or twice a day. The tablets should be kept out of reach of children and stored in a well-closed container at 20° to 25°C. The medication is manufactured and distributed by Sunrise Pharmaceutical, Inc.*

FDA Label Image

C1789516-figure-04 (C1789516 Figure 04)

This text provides information about a medication containing Benztropine Mesylate, with a usual adult dosage for parkinsonism and drug-induced extrapyramidal disorders. It also mentions instructions for storage and dissemination. The medication is in tablet form and is manufactured and distributed by Sunrise Pharmaceutical, Inc.*

FDA Label Image

C1789516-figure-05 (C1789516 Figure 05)

This text contains information about Benztropine Mesylate tablets, which are used for parkinsonism and drug-induced extrapyramidal disorders. The recommended dosage ranges from 1 to 4 mg daily. It emphasizes keeping the drug out of reach of children and storing it in a closed container between 20°C to 25°C. The tablets are manufactured and distributed by Sunrise Pharmaceutical, Inc. in Rahway, NJ.*

FDA Label Image

C1789516-figure-06 (C1789516 Figure 06)

This text contains information about Benztropine Mesylate tablets, USP. It provides details on dosage for parkinsonism and drug-induced extrapyramidal disorders. The medication should be kept out of reach of children and stored in a well-closed container at a temperature between 20° to 25°C. The tablets are manufactured and distributed by Sunrise Pharmaceutical, Inc.*

FDA Label Image

C1789516-figure-07 (C1789516 Figure 07)

This text provides important information about Benztropine Mesylate tablets, USP. The tablets come in a pack of 1000 and each tablet contains a certain amount of the active ingredient. The recommended adult dosage for parkinsonism and drug-induced extrapyramidal disorders is detailed here. It also specifies storage instructions and details related to the manufacturer, Sunrise Pharmaceutical, Inc. This drug should be kept out of reach of children and dispensed in a well-closed container.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.